SWARTZ ROBIN (Chief Operating Officer) sold 3.1% of their position (6.46K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $24.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0001104659-26-020183
Officer· Chief Operating Officer
Since Feb 2022
-6.46K
Net shares
Net seller
$24.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.46K
Price / share
$3.77
Trade value
$24.35K
% of position
3.1%
2/24/2026
206.20K→199.74K
Total
Net shares
−6.46K
Net value
-$24.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | S · Sale | −6.46K | $3.77 | $24.35K | 3.1% | 206.20K | 199.74K |
| Total | −6.46K | -$24.35K | ||||||
Derivative Transactions0
No derivative transactions reported